25 XP   0   0   10

Hybrigenics
Buy, Hold or Sell?

Let's analyse Hybrigenics together

PenkeI guess you are interested in Hybrigenics. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hybrigenics. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hybrigenics

I send you an email if I find something interesting about Hybrigenics.

Quick analysis of Hybrigenics (30 sec.)










What can you expect buying and holding a share of Hybrigenics? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
€0.03
Expected worth in 1 year
€0.04
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
€0.01
Return On Investment
89.3%

For what price can you sell your share?

Current Price per Share
€0.01
Expected price per share
€0.0115 - €0.0122
How sure are you?
50%

1. Valuation of Hybrigenics (5 min.)




Live pricePrice per Share (EOD)

€0.01

2. Growth of Hybrigenics (5 min.)




Is Hybrigenics growing?

Current yearPrevious yearGrowGrow %
How rich?$10.8m$10m$853.2k7.8%

How much money is Hybrigenics making?

Current yearPrevious yearGrowGrow %
Making money-$599.9k$315.9k-$915.9k-152.7%
Net Profit Margin-36,126.3%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Hybrigenics (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#674 / 1016

Most Revenue
#712 / 1016

Most Profit
#212 / 1016

Most Efficient
#986 / 1016

What can you expect buying and holding a share of Hybrigenics? (5 min.)

Welcome investor! Hybrigenics's management wants to use your money to grow the business. In return you get a share of Hybrigenics.

What can you expect buying and holding a share of Hybrigenics?

First you should know what it really means to hold a share of Hybrigenics. And how you can make/lose money.

Speculation

The Price per Share of Hybrigenics is €0.012. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hybrigenics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hybrigenics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.03. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hybrigenics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.00-16.7%0.00-16.7%0.00-2.1%-0.01-54.5%-0.01-92.4%
Usd Book Value Change Per Share0.0023.8%0.0023.8%0.02134.3%0.006.4%0.0026.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0023.8%0.0023.8%0.02134.3%0.006.4%0.0026.3%
Usd Price Per Share0.07-0.07-0.14-0.13-0.69-
Price to Earnings Ratio-32.81--32.81--565.08--169.16--146.91-
Price-to-Total Gains Ratio23.08-23.08-8.63--33.52-27.80-
Price to Book Ratio1.81-1.81-4.14-8.88-36.23-
Price-to-Total Gains Ratio23.08-23.08-8.63--33.52-27.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0127752
Number of shares78276
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (78276 shares)223.1859.81
Gains per Year (78276 shares)892.73239.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
108938830239229
20178517760478468
30267826690718707
40357135620957946
5044644455011961185
6053565348014351424
7062496241016751663
8071427134019141902
9080358027021532141
10089278920023922380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.014.04.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%8.010.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.017.05.6%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%8.010.00.044.4%

Fundamentals of Hybrigenics

About Hybrigenics

Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.

Fundamental data was last updated by Penke on 2024-04-09 12:19:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.

1.1. Profitability of Hybrigenics.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hybrigenics earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • A Net Profit Margin of -36,126.3% means that €-361.26 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hybrigenics:

  • The MRQ is -36,126.3%. The company is making a huge loss. -2
  • The TTM is -36,126.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-36,126.3%TTM-36,126.3%0.0%
TTM-36,126.3%YOY--36,126.3%
TTM-36,126.3%5Y56,554.5%-92,680.8%
5Y56,554.5%10Y28,202.5%+28,352.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36,126.3%-199.6%-35,926.7%
TTM-36,126.3%-213.0%-35,913.3%
YOY--279.3%+279.3%
5Y56,554.5%-438.4%+56,992.9%
10Y28,202.5%-605.5%+28,808.0%
1.1.2. Return on Assets

Shows how efficient Hybrigenics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • -3.7% Return on Assets means that Hybrigenics generated €-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hybrigenics:

  • The MRQ is -3.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.7%TTM-3.7%0.0%
TTM-3.7%YOY2.3%-6.0%
TTM-3.7%5Y-42.1%+38.4%
5Y-42.1%10Y-36.0%-6.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.7%-13.5%+9.8%
TTM-3.7%-12.9%+9.2%
YOY2.3%-11.8%+14.1%
5Y-42.1%-14.1%-28.0%
10Y-36.0%-16.0%-20.0%
1.1.3. Return on Equity

Shows how efficient Hybrigenics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • -5.5% Return on Equity means Hybrigenics generated €-0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hybrigenics:

  • The MRQ is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-5.5%0.0%
TTM-5.5%YOY3.1%-8.7%
TTM-5.5%5Y-122.7%+117.2%
5Y-122.7%10Y-87.6%-35.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.5%-16.9%+11.4%
TTM-5.5%-16.1%+10.6%
YOY3.1%-15.1%+18.2%
5Y-122.7%-19.9%-102.8%
10Y-87.6%-20.9%-66.7%

1.2. Operating Efficiency of Hybrigenics.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hybrigenics is operating .

  • Measures how much profit Hybrigenics makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • An Operating Margin of -37,829.8% means the company generated €-378.30  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hybrigenics:

  • The MRQ is -37,829.8%. The company is operating very inefficient. -2
  • The TTM is -37,829.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-37,829.8%TTM-37,829.8%0.0%
TTM-37,829.8%YOY--37,829.8%
TTM-37,829.8%5Y53,748.4%-91,578.2%
5Y53,748.4%10Y26,800.0%+26,948.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37,829.8%-295.1%-37,534.7%
TTM-37,829.8%-225.8%-37,604.0%
YOY--288.4%+288.4%
5Y53,748.4%-477.4%+54,225.8%
10Y26,800.0%-625.6%+27,425.6%
1.2.2. Operating Ratio

Measures how efficient Hybrigenics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 379.30 means that the operating costs are €379.30 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Hybrigenics:

  • The MRQ is 379.297. The company is inefficient in keeping operating costs low. -1
  • The TTM is 379.297. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ379.297TTM379.2970.000
TTM379.297YOY-+379.297
TTM379.2975Y-536.884+916.181
5Y-536.88410Y-267.221-269.663
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ379.2973.090+376.207
TTM379.2973.264+376.033
YOY-3.783-3.783
5Y-536.8845.679-542.563
10Y-267.2217.894-275.115

1.3. Liquidity of Hybrigenics.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hybrigenics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.73 means the company has €1.73 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Hybrigenics:

  • The MRQ is 1.734. The company is able to pay all its short-term debts. +1
  • The TTM is 1.734. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.734TTM1.7340.000
TTM1.734YOY1.208+0.526
TTM1.7345Y2.496-0.762
5Y2.49610Y2.773-0.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7343.914-2.180
TTM1.7344.220-2.486
YOY1.2085.388-4.180
5Y2.4966.045-3.549
10Y2.7736.406-3.633
1.3.2. Quick Ratio

Measures if Hybrigenics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • A Quick Ratio of 1.68 means the company can pay off €1.68 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hybrigenics:

  • The MRQ is 1.679. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.679. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.679TTM1.6790.000
TTM1.679YOY0.437+1.242
TTM1.6795Y0.634+1.045
5Y0.63410Y1.215-0.581
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6793.572-1.893
TTM1.6793.998-2.319
YOY0.4375.390-4.953
5Y0.6345.969-5.335
10Y1.2156.287-5.072

1.4. Solvency of Hybrigenics.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hybrigenics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hybrigenics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33 means that Hybrigenics assets are financed with 32.7% credit (debt) and the remaining percentage (100% - 32.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hybrigenics:

  • The MRQ is 0.327. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.327. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.327TTM0.3270.000
TTM0.327YOY0.283+0.044
TTM0.3275Y0.328-0.001
5Y0.32810Y0.360-0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3270.336-0.009
TTM0.3270.334-0.007
YOY0.2830.269+0.014
5Y0.3280.366-0.038
10Y0.3600.390-0.030
1.4.2. Debt to Equity Ratio

Measures if Hybrigenics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hybrigenics to the Biotechnology industry mean.
  • A Debt to Equity ratio of 48.6% means that company has €0.49 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hybrigenics:

  • The MRQ is 0.486. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.486. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.486TTM0.4860.000
TTM0.486YOY0.394+0.091
TTM0.4865Y0.687-0.202
5Y0.68710Y0.757-0.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4860.382+0.104
TTM0.4860.396+0.090
YOY0.3940.335+0.059
5Y0.6870.434+0.253
10Y0.7570.465+0.292

2. Market Valuation of Hybrigenics

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Hybrigenics generates.

  • Above 15 is considered overpriced but always compare Hybrigenics to the Biotechnology industry mean.
  • A PE ratio of -32.81 means the investor is paying €-32.81 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hybrigenics:

  • The EOD is -6.372. Based on the earnings, the company is expensive. -2
  • The MRQ is -32.814. Based on the earnings, the company is expensive. -2
  • The TTM is -32.814. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.372MRQ-32.814+26.443
MRQ-32.814TTM-32.8140.000
TTM-32.814YOY-565.079+532.265
TTM-32.8145Y-169.165+136.351
5Y-169.16510Y-146.910-22.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.372-2.259-4.113
MRQ-32.814-2.569-30.245
TTM-32.814-2.664-30.150
YOY-565.079-4.120-560.959
5Y-169.165-6.258-162.907
10Y-146.910-6.171-140.739
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hybrigenics:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-48.714+48.714
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.246+3.246
TTM--3.488+3.488
YOY--5.620+5.620
5Y--8.315+8.315
10Y-48.714-8.826-39.888
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hybrigenics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.81 means the investor is paying €1.81 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Hybrigenics:

  • The EOD is 0.351. Based on the equity, the company is cheap. +2
  • The MRQ is 1.807. Based on the equity, the company is underpriced. +1
  • The TTM is 1.807. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.351MRQ1.807-1.456
MRQ1.807TTM1.8070.000
TTM1.807YOY4.144-2.336
TTM1.8075Y8.884-7.076
5Y8.88410Y36.225-27.342
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3511.851-1.500
MRQ1.8072.090-0.283
TTM1.8072.095-0.288
YOY4.1442.844+1.300
5Y8.8843.466+5.418
10Y36.2253.815+32.410
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hybrigenics compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0030.0030%0.015-82%0.001+273%0.003-9%
Book Value Per Share--0.0340.0340%0.032+8%0.021+65%0.027+27%
Current Ratio--1.7341.7340%1.208+44%2.496-31%2.773-37%
Debt To Asset Ratio--0.3270.3270%0.283+16%0.3280%0.360-9%
Debt To Equity Ratio--0.4860.4860%0.394+23%0.687-29%0.757-36%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.002-0.0020%0.000-88%-0.006+226%-0.010+453%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.008-1%
Market Cap3590891.904-415%18493093.30618493093.3060%39080873.555-53%35747328.904-48%194725090.724-91%
Net Profit Margin---361.263-361.2630%--100%565.545-164%282.025-228%
Operating Margin---378.298-378.2980%--100%537.484-170%268.000-241%
Operating Ratio--379.297379.2970%-+100%-536.884+242%-267.221+170%
Pb Ratio0.351-415%1.8071.8070%4.144-56%8.884-80%36.225-95%
Pe Ratio-6.372+81%-32.814-32.8140%-565.079+1622%-169.165+416%-146.910+348%
Price Per Share0.012-415%0.0620.0620%0.131-53%0.119-48%0.651-91%
Price To Free Cash Flow Ratio----0%-0%-0%-48.7140%
Price To Total Gains Ratio4.481-415%23.07523.0750%8.630+167%-33.522+245%27.798-17%
Quick Ratio--1.6791.6790%0.437+284%0.634+165%1.215+38%
Return On Assets---0.037-0.0370%0.023-264%-0.421+1036%-0.360+872%
Return On Equity---0.055-0.0550%0.031-275%-1.227+2129%-0.876+1491%
Total Gains Per Share--0.0030.0030%0.015-82%0.001+273%0.003-10%
Usd Book Value--10893930.43610893930.4360%10040728.058+8%6617351.648+65%8575145.564+27%
Usd Book Value Change Per Share--0.0030.0030%0.016-82%0.001+273%0.003-9%
Usd Book Value Per Share--0.0360.0360%0.034+8%0.022+65%0.029+27%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.002-0.0020%0.000-88%-0.007+226%-0.011+453%
Usd Free Cash Flow----0%-0%-0%-2418345.3600%
Usd Market Cap3822863.521-415%19687747.13319687747.1330%41605497.987-53%38056606.352-48%207304331.585-91%
Usd Price Per Share0.013-415%0.0660.0660%0.139-53%0.127-48%0.693-91%
Usd Profit---599976.622-599976.6220%315930.696-290%-1925372.323+221%-3336424.781+456%
Usd Revenue--1660.7761660.7760%-+100%66668.872-98%2300080.756-100%
Usd Total Gains Per Share--0.0030.0030%0.016-82%0.001+273%0.003-10%
 EOD+2 -5MRQTTM+0 -0YOY+9 -185Y+18 -910Y+13 -17

3.2. Fundamental Score

Let's check the fundamental score of Hybrigenics based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.372
Price to Book Ratio (EOD)Between0-10.351
Net Profit Margin (MRQ)Greater than0-361.263
Operating Margin (MRQ)Greater than0-378.298
Quick Ratio (MRQ)Greater than11.679
Current Ratio (MRQ)Greater than11.734
Debt to Asset Ratio (MRQ)Less than10.327
Debt to Equity Ratio (MRQ)Less than10.486
Return on Equity (MRQ)Greater than0.15-0.055
Return on Assets (MRQ)Greater than0.05-0.037
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Hybrigenics based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.368
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.013
Ma 100Greater thanMa 2000.016
OpenGreater thanClose0.012
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets15,202
Total Liabilities4,969
Total Stockholder Equity10,233
 As reported
Total Liabilities 4,969
Total Stockholder Equity+ 10,233
Total Assets = 15,202

Assets

Total Assets15,202
Total Current Assets4,748
Long-term Assets10,454
Total Current Assets
Cash And Cash Equivalents 598
Net Receivables 4,000
Inventory 50
Other Current Assets 100
Total Current Assets  (as reported)4,748
Total Current Assets  (calculated)4,748
+/-0
Long-term Assets
Property Plant Equipment 20
Intangible Assets 295
Long-term Assets Other 10,138
Long-term Assets  (as reported)10,454
Long-term Assets  (calculated)10,454
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,738
Long-term Liabilities2,231
Total Stockholder Equity10,233
Total Current Liabilities
Short-term Debt 2,238
Short Long Term Debt 2,238
Accounts payable 422
Other Current Liabilities 79
Total Current Liabilities  (as reported)2,738
Total Current Liabilities  (calculated)4,975
+/- 2,238
Long-term Liabilities
Long-term Liabilities  (as reported)2,231
Long-term Liabilities  (calculated)0
+/- 2,231
Total Stockholder Equity
Common Stock2,737
Retained Earnings -1,695
Other Stockholders Equity 9,190
Total Stockholder Equity (as reported)10,233
Total Stockholder Equity (calculated)10,233
+/- 0
Other
Capital Stock2,737
Cash and Short Term Investments 598
Common Stock Shares Outstanding 273,744
Liabilities and Stockholders Equity 15,202
Net Debt 1,640
Net Invested Capital 12,470
Net Working Capital 2,010
Property Plant and Equipment Gross 84
Short Long Term Debt Total 2,238



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
20,089
16,108
15,944
9,534
8,336
6,974
5,844
7,080
7,918
16,946
21,301
16,182
13,973
3,995
5,911
6,421
13,151
15,202
15,20213,1516,4215,9113,99513,97316,18221,30116,9467,9187,0805,8446,9748,3369,53415,94416,10820,089
   > Total Current Assets 
0
0
0
0
5,809
5,024
4,696
6,194
6,785
15,650
19,584
15,048
12,671
3,408
3,435
3,969
4,492
4,748
4,7484,4923,9693,4353,40812,67115,04819,58415,6506,7856,1944,6965,0245,8090000
       Cash And Cash Equivalents 
559
22
34
2,336
3,569
2,348
21
3,460
2,434
9,649
11,716
8,489
7,015
1,912
59
0
1,541
598
5981,5410591,9127,0158,48911,7169,6492,4343,460212,3483,5692,3363422559
       Short-term Investments 
12,739
8,873
8,266
31
56
17
1,682
2,712
1,539
9,264
86
0
0
0
0
0
0
0
0000000869,2641,5392,7121,6821756318,2668,87312,739
       Net Receivables 
2,648
2,669
2,412
2,936
1,694
2,384
2,916
2,144
3,364
3,614
5,529
546
1,276
72
90
92
85
4,000
4,000859290721,2765465,5293,6143,3642,1442,9162,3841,6942,9362,4122,6692,648
       Inventory 
122
686
497
818
448
216
153
519
896
2,011
150
55
0
0
0
0
0
50
5000000551502,011896519153216448818497686122
   > Long-term Assets 
0
0
0
0
2,527
1,950
1,148
885
1,133
1,294
1,717
1,132
1,302
585
2,477
2,452
8,659
10,454
10,4548,6592,4522,4775851,3021,1321,7171,2941,1338851,1481,9502,5270000
       Property Plant Equipment 
2,659
2,142
1,697
1,346
976
715
387
266
241
598
585
326
238
47
36
28
21
20
20212836472383265855982412663877159761,3461,6972,1422,659
       Goodwill 
0
0
0
0
0
0
0
0
154
177
0
0
0
0
0
0
0
0
0000000017715400000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
101
0
0
0
0
0
00000101000000000000
       Intangible Assets 
994
1,357
2,121
1,569
1,327
993
620
333
434
444
822
523
518
0
0
0
0
295
29500005185238224444343336209931,3271,5692,1211,357994
       Other Assets 
0
6
19
96
5
244
243
248
265
216
313
284
445
2
0
0
0
0
000024452843132162652482432445961960
> Total Liabilities 
5,677
5,243
5,780
5,668
5,677
7,290
6,759
5,697
5,471
5,940
5,326
5,300
4,814
2,713
682
1,518
3,720
4,969
4,9693,7201,5186822,7134,8145,3005,3265,9405,4715,6976,7597,2905,6775,6685,7805,2435,677
   > Total Current Liabilities 
1,607
2,740
3,335
3,014
3,225
3,841
2,140
3,452
3,698
4,608
4,698
4,956
4,509
2,646
610
1,518
3,720
2,738
2,7383,7201,5186102,6464,5094,9564,6984,6083,6983,4522,1403,8413,2253,0143,3352,7401,607
       Short-term Debt 
0
0
0
0
81
271
1,682
190
179
181
287
91
97
100
68
1,086
3,477
2,238
2,2383,4771,0866810097912871811791901,682271810000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
499
637
83
91
97
100
68
1,086
3,477
2,238
2,2383,4771,0866810097918363749900000000
       Accounts payable 
734
1,398
1,855
1,586
1,563
1,579
1,163
1,316
1,145
2,076
1,727
1,565
2,409
994
296
352
182
422
4221823522969942,4091,5651,7272,0761,1451,3161,1631,5791,5631,5861,8551,398734
       Other Current Liabilities 
871
1,321
1,103
1,330
1,591
2,008
2,300
1,945
2,373
1,213
1,246
244
2,003
1,551
0
2
1
79
791201,5512,0032441,2461,2132,3731,9452,3002,0081,5911,3301,1031,321871
   > Long-term Liabilities 
0
0
0
0
2,452
3,449
4,619
2,245
1,773
1,332
628
344
305
67
72
0
0
2,231
2,2310072673053446281,3321,7732,2454,6193,4492,4520000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
100
296
352
1,085
0
01,0853522961000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
-2
-1
3
0
0
0
0
00003-1-200000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
6
0
0
0
0
0
0
0
0
0
000000000600000000
> Total Stockholder Equity
14,412
10,865
10,164
3,866
2,718
0
0
1,349
2,411
11,557
15,903
10,805
9,159
1,282
5,230
4,903
9,431
10,233
10,2339,4314,9035,2301,2829,15910,80515,90311,5572,4111,349002,7183,86610,16410,86514,412
   Common Stock
906
906
977
1,014
1,157
1,247
1,397
1,821
2,265
2,942
3,580
3,580
4,675
4,675
2,338
2,338
2,612
2,737
2,7372,6122,3382,3384,6754,6753,5803,5802,9422,2651,8211,3971,2471,1571,014977906906
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 00-49-4,545-4,579-4,388-4,641-7,140-6,787-6,725-6,625-4,221-6,05000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
84,810
89,856
89,856
3,628
3,628
7,950
0
07,9503,6283,62889,85689,85684,81000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
-1
-65,798
-68,112
-72,328
16,829
94,435
3,628
3,628
7,950
9,190
9,1907,9503,6283,62894,43516,829-72,328-68,112-65,798-100000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2
Cost of Revenue-0
Gross Profit22
 
Operating Income (+$)
Gross Profit2
Operating Expense-592
Operating Income-590-590
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense5920
 
Net Interest Income (+$)
Interest Income77
Interest Expense-57
Other Finance Cost-0
Net Interest Income21
 
Pretax Income (+$)
Operating Income-590
Net Interest Income21
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-572-608
EBIT - interestExpense = -647
-572
-507
Interest Expense57
Earnings Before Interest and Taxes (EBIT)-590-516
Earnings Before Interest and Taxes (EBITDA)-508
 
After tax Income (+$)
Income Before Tax-572
Tax Provision-0
Net Income From Continuing Ops-572-572
Net Income-564
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses592
Total Other Income/Expenses Net18-21
 

Technical Analysis of Hybrigenics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hybrigenics. The general trend of Hybrigenics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hybrigenics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hybrigenics.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0116 < 0.0122 < 0.0122.

The bearish price targets are: 0.0115.

Tweet this
Hybrigenics Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hybrigenics. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hybrigenics Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hybrigenics. The current macd is -0.00037691.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hybrigenics price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hybrigenics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hybrigenics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hybrigenics Daily Moving Average Convergence/Divergence (MACD) ChartHybrigenics Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hybrigenics. The current adx is 14.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hybrigenics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hybrigenics Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hybrigenics. The current sar is 0.01222038.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hybrigenics Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hybrigenics. The current rsi is 43.37. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Hybrigenics Daily Relative Strength Index (RSI) ChartHybrigenics Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hybrigenics. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hybrigenics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hybrigenics Daily Stochastic Oscillator ChartHybrigenics Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hybrigenics. The current cci is -90.5982906.

Hybrigenics Daily Commodity Channel Index (CCI) ChartHybrigenics Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hybrigenics. The current cmo is -5.49061033.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hybrigenics Daily Chande Momentum Oscillator (CMO) ChartHybrigenics Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hybrigenics. The current willr is -45.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hybrigenics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hybrigenics Daily Williams %R ChartHybrigenics Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hybrigenics.

Hybrigenics Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hybrigenics. The current atr is 0.00062603.

Hybrigenics Daily Average True Range (ATR) ChartHybrigenics Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hybrigenics. The current obv is 12,501,634.

Hybrigenics Daily On-Balance Volume (OBV) ChartHybrigenics Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hybrigenics. The current mfi is 30.21.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hybrigenics Daily Money Flow Index (MFI) ChartHybrigenics Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hybrigenics.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hybrigenics Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hybrigenics based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.368
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.013
Ma 100Greater thanMa 2000.016
OpenGreater thanClose0.012
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hybrigenics with someone you think should read this too:
  • Are you bullish or bearish on Hybrigenics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hybrigenics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hybrigenics

I send you an email if I find something interesting about Hybrigenics.


Comments

How you think about this?

Leave a comment

Stay informed about Hybrigenics.

Receive notifications about Hybrigenics in your mailbox!